1. Ogawa M, Okamura T, Ishikura S, Doi K, Matsuzaki H, Tanaka Y, Ota T, Hayakawa K, Suzuki H, Tsunoda T, Sasazuki T, Shirasawa S. Zfat-deficiency results in a loss of CD3zeta phosphorylation with dysregulation of ERK and Egr activities leading to impaired positive selection. PLoS One, 8: e76254, 2013
2. Tsunoda T, Shirasawa S. Roles of ZFAT in haematopoiesis, angiogenesis and cancer development. Anticancer Res, 33(7):2833-2837, 2013
3. Kiyohara C, Miyake Y, Koyanagi M, Fujimoto T, Shirasawa S, Tanaka K, Fukushima W, Sasaki S, Tsuboi Y, Yamada T, Oeda T, Shimada H, Kawamura N, Sakae N, Fukuyama H, Hirota Y, Nagai M; Fukuoka Kinki Parkinson's Disease Study Group. MDR1 C3435T polymorphism and interaction with environmental factors in risk of Parkinson's disease: a case-control study in Japan. Drug Metab Pharmacokinet, 28(2):138-143, 2013
4. Matsuzaki H, Fujimoto T, Tanaka M, Shirasawa S. Tespa1 is a novel component of mitochondria-associated endoplasmic reticulum membranes and affects mitochondrial calcium flux. Biochem Biophys Res Commun, 433(3):322-326, 2013
5. Fujimoto T, Matsuzaki H, Tanaka M, Shirasawa S. Tespa1 protein is phosphorylated in response to store-operated calcium entry. Biochem Biophys Res Commun, 434(1):162-165, 2013
6. Yotsumoto F, Tokunaga E, Oki E, Maehara Y, Yamada H, Nakajima K, Nam SO, Miyata K, Koyanagi M, Doi K, Shirasawa S, Kuroki M Professor, Miyamoto S. Molecular hierarchy of heparin-binding epidermal growth factor-like growth factor-regulated angiogenesis in triple negative breast cancer. Mol Cancer Res, 11(5):506-517, 2013
7. Vartanian S, Bentley C, Brauer MJ, Li L, Shirasawa S, Sasazuki T, Kim JS, Haverty P, Stawiski E, Modrusan Z, Waldman T, Stokoe D. Identification of mutant KRas-dependent phenotypes using a panel of isogenic cell lines. J Biol Chem, 288(4): 2403-2413, 2013
2. Tsunoda T, Shirasawa S. Roles of ZFAT in haematopoiesis, angiogenesis and cancer development. Anticancer Res, 33(7):2833-2837, 2013
3. Kiyohara C, Miyake Y, Koyanagi M, Fujimoto T, Shirasawa S, Tanaka K, Fukushima W, Sasaki S, Tsuboi Y, Yamada T, Oeda T, Shimada H, Kawamura N, Sakae N, Fukuyama H, Hirota Y, Nagai M; Fukuoka Kinki Parkinson's Disease Study Group. MDR1 C3435T polymorphism and interaction with environmental factors in risk of Parkinson's disease: a case-control study in Japan. Drug Metab Pharmacokinet, 28(2):138-143, 2013
4. Matsuzaki H, Fujimoto T, Tanaka M, Shirasawa S. Tespa1 is a novel component of mitochondria-associated endoplasmic reticulum membranes and affects mitochondrial calcium flux. Biochem Biophys Res Commun, 433(3):322-326, 2013
5. Fujimoto T, Matsuzaki H, Tanaka M, Shirasawa S. Tespa1 protein is phosphorylated in response to store-operated calcium entry. Biochem Biophys Res Commun, 434(1):162-165, 2013
6. Yotsumoto F, Tokunaga E, Oki E, Maehara Y, Yamada H, Nakajima K, Nam SO, Miyata K, Koyanagi M, Doi K, Shirasawa S, Kuroki M Professor, Miyamoto S. Molecular hierarchy of heparin-binding epidermal growth factor-like growth factor-regulated angiogenesis in triple negative breast cancer. Mol Cancer Res, 11(5):506-517, 2013
7. Vartanian S, Bentley C, Brauer MJ, Li L, Shirasawa S, Sasazuki T, Kim JS, Haverty P, Stawiski E, Modrusan Z, Waldman T, Stokoe D. Identification of mutant KRas-dependent phenotypes using a panel of isogenic cell lines. J Biol Chem, 288(4): 2403-2413, 2013